# Lubiprostone

NDC: 60687-827
Generic name: Lubiprostone
Labeler / Manufacturer: American Health Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 20251126

FDA application: ANDA209920

## Active ingredients

- LUBIPROSTONE: 24 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60687-827"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60687-827
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3014dd6d-9c05-479d-b79d-7a49f78a1ce5